JP2019513344A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019513344A5 JP2019513344A5 JP2018541250A JP2018541250A JP2019513344A5 JP 2019513344 A5 JP2019513344 A5 JP 2019513344A5 JP 2018541250 A JP2018541250 A JP 2018541250A JP 2018541250 A JP2018541250 A JP 2018541250A JP 2019513344 A5 JP2019513344 A5 JP 2019513344A5
- Authority
- JP
- Japan
- Prior art keywords
- psgl
- protein
- recombinant chimeric
- recombinant
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100034925 P-selectin glycoprotein ligand 1 Human genes 0.000 claims 29
- 108010054395 P-selectin ligand protein Proteins 0.000 claims 29
- 235000018102 proteins Nutrition 0.000 claims 7
- 102000004169 proteins and genes Human genes 0.000 claims 7
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 5
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 5
- 150000001413 amino acids Chemical group 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 4
- 102000003800 Selectins Human genes 0.000 claims 4
- 108090000184 Selectins Proteins 0.000 claims 4
- AAEVYOVXGOFMJO-UHFFFAOYSA-N prometryn Chemical compound CSC1=NC(NC(C)C)=NC(NC(C)C)=N1 AAEVYOVXGOFMJO-UHFFFAOYSA-N 0.000 claims 4
- 230000001737 promoting effect Effects 0.000 claims 4
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 3
- 235000018417 cysteine Nutrition 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 239000001963 growth medium Substances 0.000 claims 2
- 239000000710 homodimer Substances 0.000 claims 2
- 238000003384 imaging method Methods 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 238000002600 positron emission tomography Methods 0.000 claims 2
- 238000002603 single-photon emission computed tomography Methods 0.000 claims 2
- 125000006850 spacer group Chemical group 0.000 claims 2
- 238000002604 ultrasonography Methods 0.000 claims 2
- 239000013598 vector Substances 0.000 claims 2
- 108020004414 DNA Proteins 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- RWCOTTLHDJWHRS-YUMQZZPRSA-N Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RWCOTTLHDJWHRS-YUMQZZPRSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000002591 computed tomography Methods 0.000 claims 1
- 238000002059 diagnostic imaging Methods 0.000 claims 1
- 210000003527 eukaryotic cell Anatomy 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 230000002018 overexpression Effects 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 108010094020 polyglycine Proteins 0.000 claims 1
- 229920000232 polyglycine polymer Polymers 0.000 claims 1
- 108010077112 prolyl-proline Proteins 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000001131 transforming effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16154868 | 2016-02-09 | ||
| EP16154868.0 | 2016-02-09 | ||
| PCT/EP2017/052821 WO2017137477A1 (en) | 2016-02-09 | 2017-02-09 | A recombinant chimeric protein for selectins targeting |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019513344A JP2019513344A (ja) | 2019-05-30 |
| JP2019513344A5 true JP2019513344A5 (enExample) | 2020-03-19 |
| JP6991148B2 JP6991148B2 (ja) | 2022-01-12 |
Family
ID=55435965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018541250A Active JP6991148B2 (ja) | 2016-02-09 | 2017-02-09 | セレクチン標的化のための組み換えキメラタンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11370826B2 (enExample) |
| JP (1) | JP6991148B2 (enExample) |
| KR (1) | KR102771920B1 (enExample) |
| CN (1) | CN108699130A (enExample) |
| AU (1) | AU2017218024B2 (enExample) |
| BR (1) | BR112018015143A2 (enExample) |
| CA (1) | CA3011248A1 (enExample) |
| IL (1) | IL260957B2 (enExample) |
| WO (1) | WO2017137477A1 (enExample) |
| ZA (1) | ZA201804657B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2731524T3 (es) | 2012-04-05 | 2019-11-15 | Massachusetts Inst Technology | Composiciones inmunoestimuladoras y métodos de uso de las mismas |
| EP3580231A1 (en) * | 2017-02-09 | 2019-12-18 | Bracco Suisse SA | Process for the purification of soluble psgl-1 protein variants |
| JP7654240B2 (ja) * | 2017-09-19 | 2025-04-01 | マサチューセッツ インスティテュート オブ テクノロジー | キメラ抗原受容体ｔ細胞治療のための組成物およびその使用 |
| WO2019191519A1 (en) * | 2018-03-28 | 2019-10-03 | Orionis Biosciences, Inc. | Bi-functional proteins and construction thereof |
| JP7539380B2 (ja) * | 2018-12-21 | 2024-08-23 | ブラッコ・スイス・ソシエテ・アノニム | リガンドを含むガス充填微小胞 |
| US12453777B2 (en) | 2019-03-20 | 2025-10-28 | Massachusetts Institute Of Technology | Uses of amphiphiles in immune cell therapy and compositions therefor |
| US20240108747A1 (en) * | 2019-03-21 | 2024-04-04 | Lonza Sales Ag | Extracellular vesicle conjugates and uses thereof |
| WO2021183685A2 (en) * | 2020-03-10 | 2021-09-16 | Shaw Gray D | Fusion molecules of psgl-1 or tsgl anionic domains to checkpoint-modulating antibodies and other antibodies |
| US20220184203A1 (en) * | 2020-03-31 | 2022-06-16 | Engimata, Inc | Immunogenic composition forming a vaccine, and a method for its manufacture |
| WO2022006564A1 (en) * | 2020-07-03 | 2022-01-06 | The Trustees Of Columbia University In The City Of New York | Polyfunctional orthogonal protein chimeras |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4276885A (en) | 1979-05-04 | 1981-07-07 | Rasor Associates, Inc | Ultrasonic image enhancement |
| US5362476A (en) | 1984-10-18 | 1994-11-08 | Board Of Regents, The University Of Texas System | Alkyl phosphonate polyazamacrocyclic cheates for MRI |
| MX174467B (es) | 1986-01-23 | 1994-05-17 | Squibb & Sons Inc | 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos |
| US5021556A (en) | 1987-07-22 | 1991-06-04 | Neorx Corporation | Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides |
| IE61591B1 (en) | 1987-12-29 | 1994-11-16 | Molecular Biosystems Inc | Concentrated stabilized microbubble-type ultrasonic imaging agent and method of production |
| US5075099A (en) | 1988-05-31 | 1991-12-24 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
| US5364613A (en) | 1989-04-07 | 1994-11-15 | Sieving Paul F | Polychelants containing macrocyclic chelant moieties |
| US5118797A (en) | 1989-08-28 | 1992-06-02 | E. R. Squibb & Sons, Inc. | Rhenium tris dioxime complexes |
| CA2034042C (en) | 1990-01-18 | 1999-08-17 | Adrian D. Nunn | Boronic acid adducts of rhenium dioxime and technetium-99m dioxime complexes containing a biochemically active group |
| IN172208B (enExample) | 1990-04-02 | 1993-05-01 | Sint Sa | |
| US5445813A (en) | 1992-11-02 | 1995-08-29 | Bracco International B.V. | Stable microbubble suspensions as enhancement agents for ultrasound echography |
| US5556610A (en) | 1992-01-24 | 1996-09-17 | Bracco Research S.A. | Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method |
| US5183653A (en) | 1990-04-13 | 1993-02-02 | E. R. Squibb & Sons, Inc. | Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds |
| AU636481B2 (en) | 1990-05-18 | 1993-04-29 | Bracco International B.V. | Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
| US5367080A (en) | 1990-11-08 | 1994-11-22 | Sterling Winthrop Inc. | Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods |
| US5965107A (en) | 1992-03-13 | 1999-10-12 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
| US5808091A (en) | 1991-10-29 | 1998-09-15 | Bracco International B.V. | Rhenium and technetium complexes containing a hypoxia localizing moiety |
| IL104084A (en) | 1992-01-24 | 1996-09-12 | Bracco Int Bv | Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them |
| US6277975B1 (en) | 1992-10-23 | 2001-08-21 | Genetics Institute, Inc. | Fusions of P-selectin ligand protein and polynucleotides encoding same |
| US5843707A (en) | 1992-10-23 | 1998-12-01 | Genetics Institute, Inc. | Nucleic acid encoding a novel P-selectin ligand protein |
| US5608110A (en) | 1993-06-15 | 1997-03-04 | Bracco International B.V. | Heteroatom-bearing ligands and metal complexes thereof |
| AU7261994A (en) | 1993-07-19 | 1995-02-20 | Resolution Pharmaceuticals Inc. | Hydrazino-type radionuclide chelators having an n3s configuration |
| US5409689A (en) | 1993-08-13 | 1995-04-25 | Concat, Ltd. | MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms |
| US5574140A (en) | 1993-09-03 | 1996-11-12 | Resolution Pharmaceutical Inc. | Hydrazino-type N2 S2 chelators |
| US5662885A (en) | 1994-07-22 | 1997-09-02 | Resolution Pharmaceuticals Inc. | Peptide derived radionuclide chelators |
| US6333021B1 (en) | 1994-11-22 | 2001-12-25 | Bracco Research S.A. | Microcapsules, method of making and their use |
| IL116328A (en) | 1994-12-16 | 1999-09-22 | Bracco Research Sa | Frozen suspension of gas microbubbles in frozen aqueous carrier for use as contrast agent in ultrasonic imaging |
| US5886142A (en) | 1997-05-20 | 1999-03-23 | Thomas Jefferson University | Radiolabeled thrombus imaging agents |
| US6093382A (en) | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| IT1315263B1 (it) | 1999-12-21 | 2003-02-03 | Bracco Spa | Composti chelanti,loro chelati con ioni metallici paramagnetici, loropreparazione ed uso |
| AU2001247929A1 (en) | 2000-03-31 | 2001-10-15 | Genetics Institute, Llc | Inhibition of thrombosis by treatment with p-selectin antagonists |
| US20040167330A1 (en) | 2001-07-17 | 2004-08-26 | Ivan Lukes | Novel chelating agents and conjugates thereof, their synthesis and use as diagnois and therapeutic agents |
| ITMI20011518A1 (it) | 2001-07-17 | 2003-01-17 | Bracco Imaging Spa | Leganti azotati multidentati capaci di complessare ioni metallici e loro uso in diagnostica e in terapia |
| DE602004029010D1 (de) | 2003-02-04 | 2010-10-21 | Bracco Suisse Sa | Ultraschall kontrastmittel und verfahren zur erstellung |
| JP2007516288A (ja) | 2003-12-23 | 2007-06-21 | ブラッコ・イメージング・ソシエタ・ペル・アチオニ | 金属キレート剤として有用な新規化合物 |
| WO2005105840A2 (en) | 2004-03-26 | 2005-11-10 | Five Prime Therapeutics, Inc. | Cd40 variants and uses thereof |
| US9333272B2 (en) | 2006-12-11 | 2016-05-10 | Bracco Imaging Spa | Fibrin binding peptide conjugates for diagnostic and therapeutic applications |
| EP2148662A4 (en) | 2007-04-20 | 2014-11-26 | Univ Oregon Health & Science | ULTRASONIC DISPLAY WITH TARGETED MICROBUMS |
| CA2806639C (en) | 2010-08-09 | 2020-10-20 | Bracco Suisse Sa | Targeted gas-filled microvesicles |
| GB201203071D0 (en) * | 2012-02-22 | 2012-04-04 | Ucb Pharma Sa | Biological products |
| EP2639227A1 (en) | 2012-03-14 | 2013-09-18 | Bracco Imaging S.p.A | A new class of diazepine derivative chelating agents and complexes with paramagnetic metals as MRI contrast agents |
| JP6227760B2 (ja) | 2013-05-30 | 2017-11-08 | ブラッコ・イメージング・ソシエタ・ペル・アチオニＢｒａｃｃｏ Ｉｍａｇｉｎｇ Ｓ．Ｐ．Ａ． | 蛍光固形脂質ナノ粒子組成物およびその製法 |
| PT3324938T (pt) | 2015-07-20 | 2021-09-21 | Trilogic Pharma Llc | Formulações tópicas e tratamentos |
-
2017
- 2017-02-09 CN CN201780010345.7A patent/CN108699130A/zh active Pending
- 2017-02-09 CA CA3011248A patent/CA3011248A1/en active Pending
- 2017-02-09 JP JP2018541250A patent/JP6991148B2/ja active Active
- 2017-02-09 AU AU2017218024A patent/AU2017218024B2/en active Active
- 2017-02-09 US US16/076,664 patent/US11370826B2/en active Active
- 2017-02-09 KR KR1020187025930A patent/KR102771920B1/ko active Active
- 2017-02-09 IL IL260957A patent/IL260957B2/en unknown
- 2017-02-09 BR BR112018015143A patent/BR112018015143A2/pt unknown
- 2017-02-09 WO PCT/EP2017/052821 patent/WO2017137477A1/en not_active Ceased
-
2018
- 2018-07-12 ZA ZA2018/04657A patent/ZA201804657B/en unknown
-
2022
- 2022-05-18 US US17/747,315 patent/US11905323B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019513344A5 (enExample) | ||
| CN102917726B (zh) | 干扰素类似物 | |
| ES2985878T3 (es) | Anticuerpo marcado con radioisótopo específico de sitio usando péptido de unión a IgG | |
| JP2014500868A (ja) | 癌及び慢性感染の治療のための作動薬活性を有するｉｌ−２由来のポリペプチド | |
| US20160130319A1 (en) | High-stability t-cell receptor and preparation method and application thereof | |
| WO2021093881A1 (zh) | 用于调控酸性环境免疫应答的组合物、其制备方法和用途 | |
| EP3574019A1 (en) | Tissue-specific wnt signal enhancing molecules and uses thereof | |
| JP2018529363A5 (enExample) | ||
| FI3368555T3 (fi) | Kaksitoimisia proteiineja ja niitä sisältävä farmaseuttinen koostumus | |
| JP2015518479A5 (enExample) | ||
| JP2010068806A5 (enExample) | ||
| KR20200143366A (ko) | 수식 항체 및 방사성 금속 표지 항체 | |
| CN110023333B (zh) | 高亲和力的可溶性pd-1分子 | |
| JP2005523681A5 (enExample) | ||
| JP5961191B2 (ja) | テクネチウム標識ペプチド | |
| CN116023438A (zh) | 一种cxcr4靶向多肽及其应用 | |
| CN112409450B (zh) | TIGIT-IgV的亲和剂及其应用 | |
| JP2022502347A (ja) | 細胞透過性ペプチド | |
| Hadac et al. | Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions | |
| Kaloudi et al. | Localization of 99mTc-GRP analogs in GRPR-expressing tumors: Effects of peptide length and neprilysin inhibition on biological responses | |
| US20180355012A1 (en) | Soluble heterodimeric t cell receptor, and preparation method and use thereof | |
| US9821080B2 (en) | In vivo methods of monitoring biodistribution | |
| CN109415410B (zh) | 靶向树突细胞的肽、利用了该肽的肽融合体、及利用了该肽融合体的疫苗 | |
| JP2008538501A5 (enExample) | ||
| JP2024506070A (ja) | 新規ｈｅｒ２結合ポリペプチド |